Literature DB >> 23559393

Proteus syndrome revealing itself after the treatment of a bilateral subdural haematoma.

Yassine El Hassani1, Benoit Jenny, Brigitte Pittet-Cuenod, Armand Bottani, Paolo Scolozzi, Hulya Ozsahin Ayse, Benédict Rilliet.   

Abstract

INTRODUCTION: Hypertrophy of the calvarium has different aetiologies, among them the rare Proteus syndrome. CASE REPORT: We report here the case of a young girl initially treated for relapsing right then left large chronic subdural haematoma, who progressively developed craniofacial hypertrophy consistent with the diagnosis of Proteus syndrome. Calvarium hypertrophy was shaved and remodelled combining midface advancement, essentially for cosmetic purposes. During the first calvarium remodelling, important bleeding of the bone required large volume of blood replacement. Haemostasis workup revealed platelets aggregation anomalies. Bleeding issues during subsequent surgeries were controlled with tranexamic acid and desmopressin acetate. DISCUSSION: Other manifestations of Proteus syndrome, such as a right hypertrophy of the face with hypoplasia of its middle third, a pigmented epidermal nevus and asymmetric limbs and scoliosis, appeared progressively over time. Blood and fibroblast phosphatase and tensin homolog mutation was not found.
CONCLUSION: Literature review of operated patients with Proteus syndrome did not reveal an association with platelets anomalies. A complete haemostasis workup following this unexpected haemorrhagic complication is recommended for this rare pathology.

Entities:  

Mesh:

Year:  2013        PMID: 23559393     DOI: 10.1007/s00381-013-2090-z

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  28 in total

1.  PTEN mutations are uncommon in Proteus syndrome.

Authors:  K Barker; A Martinez; R Wang; S Bevan; V Murday; J Shipley; R Houlston; J Harper
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

2.  Proteus syndrome: a rare cause of hemihypertrophy and macrodactyly on bone scanning.

Authors:  U Joshi; J A van der Sluijs; G J J Teule; R Pijpers
Journal:  Clin Nucl Med       Date:  2005-09       Impact factor: 7.794

Review 3.  PTEN function in normal and neoplastic growth.

Authors:  Lionel M L Chow; Suzanne J Baker
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

4.  Spontaneous subgaleal hemorrhage in a girl with impaired adrenaline-induced platelet aggregation.

Authors:  Sakara Hutspardol; Ampaiwan Chuansamrit; Anucha Soisamrong
Journal:  J Med Assoc Thai       Date:  2010-05

Review 5.  Management of craniofacial hyperostosis in Proteus syndrome.

Authors:  Yoshiaki Sakamoto; Hideo Nakajima; Kazuo Kishi; Ruka Shimizu; Tatsuo Nakajima
Journal:  J Craniofac Surg       Date:  2010-03       Impact factor: 1.046

Review 6.  Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation.

Authors:  L G Biesecker; R Happle; J B Mulliken; R Weksberg; J M Graham; D L Viljoen; M M Cohen
Journal:  Am J Med Genet       Date:  1999-06-11

Review 7.  Craniofacial hyperostoses in Proteus syndrome -- a case report.

Authors:  Nicolai Adolphs; Sigrid Tinschert; Jürgen Bier; Martin Klein
Journal:  J Craniomaxillofac Surg       Date:  2004-12       Impact factor: 2.078

8.  Cutaneous manifestations of proteus syndrome: correlations with general clinical severity.

Authors:  Diem Nguyen; Joyce T Turner; Cara Olsen; Leslie G Biesecker; Thomas N Darling
Journal:  Arch Dermatol       Date:  2004-08

Review 9.  Proteus syndrome: clinical evidence for somatic mosaicism and selective review.

Authors:  M M Cohen
Journal:  Am J Med Genet       Date:  1993-10-01

Review 10.  Proteus syndrome: diagnosis and surgical management.

Authors:  R Y Vaughn; A D Selinger; C G Howell; R A Parrish; M T Edgerton
Journal:  J Pediatr Surg       Date:  1993-01       Impact factor: 2.545

View more
  1 in total

1.  A case report of Proteus syndrome (PS).

Authors:  Xiaoyun Zeng; Xiaoming Wen; Xinxin Liang; Lina Wang; Lingling Xu
Journal:  BMC Med Genet       Date:  2020-01-21       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.